We searched PubMed using the key word “mesothelioma” with the relevant topics—eg, “pathogenesis”, “tumour suppressor genes”, “peritoneal”, “oncogenes”, “angiogenesis”, “SV40”, “cytopathology”, “palliation”, and so on. Fields were limited to publications in English and restricted to the past 15 years. We also reviewed citations from papers from the search. Where possible, primary sources are quoted, but review articles are referenced where pragmatically necessary. References were chosen
SeminarMalignant mesothelioma
Introduction
The fact that asbestos can cause cancer is now widely known in western countries, and the public are increasingly familiar with the word mesothelioma, especially since the deaths of some well known individuals with the disease, such as actor Steve McQueen and scientist and author Stephen Jay Gould.1
Why this change in awareness? One reason is that mesothelioma has climbed the league table of male cancers over the past 30 years, and is now roughly as common as cancers of the liver, bone, and bladder, especially in Europe and Australia.2 Its incidence is expected to continue to increase for the next decade or so. Secondly, almost everyone who lives in industrialised areas of the western world has asbestos fibres in their lungs, and many can remember being exposed to asbestos incidentally (eg, carpenters, plumbers, military personnel, school teachers, and students who handled asbestos samples, mats, or blankets; home renovators; and people in many other situations).3 Media interest in asbestos has produced in many of these individuals a level of awareness—even anxiety—about mesothelioma that does not exist for most other sporadic cancers of comparable incidence. These issues, combined with the complex medical–legal aspects of the disease, have led to a lot of interest. For example, a simple Google search of the common cancers at the time of writing identified nearly 3 million webpage results for mesothelioma, second only to breast cancer and substantially more than the number of results for other well known cancers such as lung cancer, leukaemia, lymphoma, and bowel or colon cancer (panel 1).
In this Seminar, we aim to review mesothelioma, highlighting key clinical features plus some controversies, recent developments, and important questions for future research into this disease.
Section snippets
Epidemiology
There are few disease processes for which the distribution and determinants of occurrence in the community are as well known as they are for mesothelioma of the pleura and peritoneum. In fact, mesothelioma owes its entire existence as a disease entity to its relation with asbestos, first recognised by an astute pathologist working in South Africa's Cape Province in the 1950s.4 As an industrial disease, it is one of the most accurately predictable. Of all the outcomes from the production and use
How does asbestos cause mesothelioma?
A single layer of mesothelial cells covers the entire surface of the pleura; these cells aid free movement of the pleural surfaces during respiration by enmeshing lubricating glycoproteins,14, 15 and are readily able to proliferate in response to injury and growth factors.16, 17 At least four plausible explanations have been proposed as to how a mineral fibre such as asbestos causes malignant change in these cells.
First, there is pleural irritation. Good epidemiological evidence shows that the
Clinical presentation
Typically, a patient with mesothelioma presents with a pleural effusion, which is often associated with chest wall pain.59 In fact, mesothelioma should be suspected in any individual with an unexplained pleural effusion associated with chest wall pain. Constitutional symptoms such as weight loss and fatigue can be present, but these generally appear later in the course of disease—the presence of such symptoms at presentation is associated with a poor prognosis.59 Occasionally, patients have no
Diagnosis
Accurate diagnosis of mesothelioma is important for several reasons, not least for clinical management of the patient. Issues of compensation also exist and, because the likelihood of survival a year beyond diagnosis is less than 50%, there may be some urgency to expedite the diagnosis for litigation purposes, especially if the jurisdiction will only accept cases brought on behalf of a living victim.
The most common diagnostic problem is distinguishing mesothelioma from adenocarcinoma,
Management of mesothelioma
In the past few years, there have been several major developments in the management of mesothelioma, especially the development of more effective therapies plus new discoveries that could improve mesothelioma diagnosis and new insights into the pathobiology of the disease.92, 93 These discoveries are producing new approaches to diagnosis and prognostication, such as DNA microarray patterns to predict outcome, and genetic information to develop novel therapies such as gene therapy.
Optimum palliation for mesothelioma (panel 4)
Recurrent pleural effusions are controlled by pleurodesis, usually involving talc instillation, and occasionally surgery. Pain is a major issue for these patients and there are several types of pain in mesothelioma. Invasion of the chest wall can cause localised somatic pain; intercostal nerve invasion or vertebral invasion can cause neuropathic pain; and lung invasion can cause diffuse visceral pain. Also common is dyspnoea due to pleural effusion or more often tumour spread.119
There is no
Prevention of mesothelioma in asbestos-exposed populations
Since the epidemic of mesothelioma began, the notion that the disease could be prevented in high-risk individuals has been suggested. In some highly exposed cohorts the lifetime risk can approach 25%. Since these individuals can be identified by their high exposure, much research has been aimed at identifying possible ways of preventing this disease. The main approach has involved dietary methods. In a study aimed at determining whether vitamin A could be protective,121 daily retinol was
Search strategy and selection criteria
References (125)
- et al.
The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure
Ann Occup Hyg
(2000) - et al.
Mesothelial progenitor cells and their potential in tissue engineering
Int J Biochem Cell Biol
(2004) - et al.
Carcinogenicity studies on fibres, metal compounds and some other dusts in rats
Exp Pathol
(1987) - et al.
Prevention of asbestos-induced cell death in rat lung fibroblasts and alveolar macrophages by scavengers of active oxygen species
Environ Res
(1987) - et al.
Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide
Arch Biochem Biophys
(1984) - et al.
Molecular pathogenesis of mesothelioma and its relationship to simian virus 40
Clin Lung Cancer
(2003) - et al.
Simian virus 40 infection in humans and association with human diseases: results and hypotheses
Virol
(2004) - et al.
Cluster of familial malignant mesothelioma with del(9p) as the sole chromosomal anomaly
Cancer Genet Cytogenet
(2002) - et al.
Parental cancer and genetic predisposition in malignant pleural mesothelioma: a case-control study
Cancer Lett
(1996) - et al.
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
Lancet
(2001)
New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents
Semin Oncol
Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer
Ann Thorac Surg
More cases of miliary mesothelioma
Chest
The role of imaging in malignant pleural mesothelioma
Semin Oncol
Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma
Hum Pathol
Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma
Lung Cancer
Pleural mesothelioma: little evidence, still time to do trials
Lancet
Malignant mesothelioma: British surgical strategies
Lung Cancer
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies
J Thorac Cardiovasc Surg
The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma
Ann Thorac Surg
Chemotherapy for malignant pleural mesothelioma
Clin Lung Cancer
Acclaimed science writer dies
Statistics
The North American experience with malignant mesothelioma
Diffuse pleural mesothelioma
Br J Ind Med
Epidemiological and environmental evidence of the health effects of exposure to erionite fibres
Int J Cancer
Malignant mesothelioma
Ultrastruct Pathol
The history of mesothelioma in Australia 1045–2001
Mesothelioma survival in Western Australia
Epidemiology of mesothelioma in Western Australia
Med J Aust
Epidemiology of mesothelioma
Comparison of measures of exposure to asbestos in former crocidolite workers from Wittenoom Gorge, W Australia
Am J Ind Med
Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia
Occup Env Med
Mesothelial cells in situ
The ultrastructural morphology and possible functional significance of mesothelial microvilli
Anat Rec
Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells
Carcinogenesis
Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura
IARC Sci Publ
Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients: part 1—diagnosis
Cancer
Behavior of crocidolite asbestos during mitosis in living vertebrate lung epithelial cells
Cancer Res
Asbestos body formation and iron accumulation in mouse peritoneal granulomas after the introduction of crocidolite asbestos fibers
Am J Pathol
Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: role of iron-catalyzed free radicals
Am J Physiol
Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor
Cancer Res
A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression
Cancer Res
Platelet derived growth factor as an autocrine factor in murine malignant mesothelioma
Eur Respir Rev
Antisense oligonucleotides specific for transforming growth factor β2 inhibit the growth of malignant mesothelioma both in vitro and in vivo
Cancer Res
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood
N Engl J Med
Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40
J Natl Cancer Inst
SV40 induces mesotheliomas in hamsters
Am J Pathol
Simian virus-40 largeT-antigen binds p53 in human mesotheliomas
Nat Med
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas
Nat Med
Cited by (673)
The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality
2023, Journal of Thoracic OncologyPleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy
2023, Journal of Thoracic and Cardiovascular SurgeryPET-CT-guided versus CT-guided biopsy in suspected malignant pleural thickening: a randomised trial
2024, European Respiratory JournalPleural mesothelioma (PMe): The evolving molecular knowledge of a rare and aggressive cancer
2024, Molecular OncologyPatient with recurrent paratesticular malignant mesothelioma and multiple primary neoplasms
2024, Journal of Men's Health